| Ytd | -6.64% | |
| 1y | -26.23% |
| Open | 4.24 | Prev Close | 4.36 | Low | 4.24 | High | 4.36 | Mkt Cap | 96.26M |
| Vol | 675.98K | Avg Vol | 724.34K | EPS | -8.57 | P/E | -0.51 | Forward P/E | -0.89 |
| Beta | 1.01 | Short Ratio | 5.53 | Inst. Own | 79.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.41 | 200-d Avg | 3.48 | 1yr Est | 29.71 |
ADVM News
Adverum Biotechnologies, Inc. (NASDAQ: ADVM - Get Free Report) has been given a consensus recommenda
Stock News Fed set for a âhawkish cutâ: The Federal Reserve is widely expected to deliver a thir
INDIANAPOLIS , Dec. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Adverum Biotechno
REDWOOD CITY, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM)
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Adverum Biotechnologies (NASDAQ: ADVM - Get Free Report) is expected to be issuing its Q3 2025 resul
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
NEW YORK , Oct. 24, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Ass
MILWAUKEE , Oct. 24, 2025 /PRNewswire/ -- The Ademi Firm is investigating Adverum (Nasdaq: ADVM) for
Eli Lilly said on Friday it would acquire gene therapy developer Adverum Biotechnologies in a deal v
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is invest
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated
Screening closing ahead of expectations, with full enrollment now anticipated in 4Q 2025 (previously
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM
- ARTEMIS Phase 3 trial enrollment exceeding expectations; driven by strong retina specialist and p
REDWOOD CITY, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM)
REDWOOD CITY, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM)
- Initiated ARTEMIS, the first-ever registrational intravitreal gene therapy trial, in both treatm
NEW YORK, NY / ACCESS Newswire / May 10, 2025 / Pomerantz LLP is investigating claims on behalf of i
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after t
On Tuesday, 298 companies achieved new lows for the year.
During Friday's trading, 293 companies set new 52-week lows.
Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Fr
Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritim
Upgrades
On Friday, 153 companies set new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Wednesday, 160 companies hit new 52-week lows.
On Tuesday, 242 companies hit new 52-week lows.
During Tuesday's session, 454 stocks hit new 52-week lows.
During Tuesday's trading, 505 companies set new 52-week lows.
On Friday, 313 companies hit new 52-week lows.
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insid
During Friday's session, 445 companies made new 52-week lows.
On Friday morning, 155 companies achieved new lows for the year.
Insider buying can be an encouraging signal for potential investors, especially when markets face
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stoc
Stocks That Hit 52-Week Highs On Wednesday